Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis
Authors:
- Martin RoderfeldMRMartin Roderfeld
- Jörg Michael HalweJHJörg Michael Halwe
- Annette TschuschnerATAnnette Tschuschner
- Elke RoebERElke Roeb
- Jürgen GrafJGJürgen Graf
- 23 June 2010
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 45 (10) , 1186-1196
Abstract
Matrix metalloproteinases (MMPs) are considered the predominant proteases in the pathogenesis of mucosal ulcerations associated with inflammatory bowel disease (IBD). Whether the malignancy associated MMP-7 and MMP-13 or the recently cloned MMP-28 convey a certain meaning for intestinal homeostasis and pathogenesis of IBD is currently unknown. We therefore set off to analyze regulation patterns and cellular origins of these MMPs in mucosal tissues of patients with ulcerative colitis (UC). Biopsy samples of affected and healthy tissues were obtained from 35 Norwegian patients with UC. RNA was quantified by quantitative real-time polymerase chain reaction to study MMP gene expression in both pathological and healthy mucosal specimens. Cellular origins were determined by immunohistology using surrogate markers for inflammation, neovascularization, and epithelial structures. Protein expression of MMP-7 and MMP-13 was quantified using enzyme-linked immunosorbent assay. MMP-7 and MMP-13 gene expression was significantly increased in UC affected colonic mucosa whereas MMP-28 showed a decreased expression in inflamed mucosa. Endothelial cells and infiltrating leukocytes were identified as the major cellular sources of MMP-7 and MMP-13 in UC. Enterocytes represented the major cellular source of MMP-28 in healthy and inflamed mucosa. MMP-7 and MMP-13 expression in inflammatory and endothelial cells indicate a role of these MMPs for both colitis associated neoangiogenesis and inflammatory changes. Decreased MMP-28 expression in UC is most likely the result of colitis associated epithelial destruction and loss of cryptal architecture.Keywords
This publication has 40 references indexed in Scilit:
- Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cellsBlood, 2009
- Inhibition of interleukin‐1β–induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2Arthritis & Rheumatism, 2008
- Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and MetastasisClinical Cancer Research, 2006
- Regulation of matrilysin expression in endothelium by fibroblast growth factor-2Biochemical and Biophysical Research Communications, 2006
- The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitisJournal of Gastroenterology, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancersInternational Journal of Cancer, 2000
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976